Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyo Sup Shim

Showing results (71-80 of 138) with videos related to

Pageof 14
Sort By:
Yonsei Medical Journal|February 19, 2024
Computed Tomography Radiomics for Preoperative Prediction of Spread Through Air Spaces in the Early Stage of Surgically Resected Lung AdenocarcinomasYoung Joo Suh, Kyunghwa Han, Yonghan Kwon, et al.
Oncotarget|March 19, 2016
Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negativeSun Min Lim, Eun Young Kim, Hye Ryun Kim, et al.
Nature Communications|October 19, 2021
Dysregulation of T<sub>FH</sub>-B-T<sub>RM</sub> lymphocyte cooperation is associated with unfavorable anti-PD-1 responses in EGFR-mutant lung cancerJae-Won Cho, Seyeon Park, Gamin Kim, et al.
Journal of Pathology and Translational Medicine|May 10, 2021
Molecular biomarker testing for non-small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study GroupSunhee Chang, Hyo Sup Shim, Tae Jung Kim, et al.
Cancer Research and Treatment|June 4, 2021
Increased Radiosensitivity of Solid Tumors Harboring ATM and BRCA1/2 MutationsKyung Hwan Kim, Han Sang Kim, Seung-Seob Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 28, 2024
Neoadjuvant and Adjuvant Osimertinib in Stage IA to IIIA, EGFR-Mutant NSCLC (NORA)Jii Bum Lee, Su-Jin Choi, Hyo Sup Shim, et al.
JCI Insight|June 20, 2020
Combination of PD-L1 and PVR determines sensitivity to PD-1 blockadeBo Ryeong Lee, Sehyun Chae, Jihyun Moon, et al.
Tuberculosis and Respiratory Diseases|November 23, 2013
Plasminogen Activator Inhibitor Type 1 (PAI-1) A15T Gene Polymorphism Is Associated with Prognosis in Patients with EGFR Mutation Positive Pulmonary AdenocarcinomaJu Eun Lim, Moo Suk Park, Eun Young Kim, et al.
Journal for Immunotherapy of Cancer|December 15, 2021
Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancerChang Gon Kim, Gamin Kim, Kyung Hwan Kim, et al.
The EMBO Journal|March 14, 2022
Airway secretory cell fate conversion via YAP-mTORC1-dependent essential amino acid metabolismHae Yon Jeon, Jinwook Choi, Lianne Kraaier, et al.
Pageof 14

Showing results (71-80 of 138) with videos related to

Sort By:
Pageof 14
Yonsei Medical Journal|February 19, 2024
Computed Tomography Radiomics for Preoperative Prediction of Spread Through Air Spaces in the Early Stage of Surgically Resected Lung AdenocarcinomasYoung Joo Suh, Kyunghwa Han, Yonghan Kwon, et al.
Oncotarget|March 19, 2016
Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negativeSun Min Lim, Eun Young Kim, Hye Ryun Kim, et al.
Nature Communications|October 19, 2021
Dysregulation of T<sub>FH</sub>-B-T<sub>RM</sub> lymphocyte cooperation is associated with unfavorable anti-PD-1 responses in EGFR-mutant lung cancerJae-Won Cho, Seyeon Park, Gamin Kim, et al.
Journal of Pathology and Translational Medicine|May 10, 2021
Molecular biomarker testing for non-small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study GroupSunhee Chang, Hyo Sup Shim, Tae Jung Kim, et al.
Cancer Research and Treatment|June 4, 2021
Increased Radiosensitivity of Solid Tumors Harboring ATM and BRCA1/2 MutationsKyung Hwan Kim, Han Sang Kim, Seung-Seob Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 28, 2024
Neoadjuvant and Adjuvant Osimertinib in Stage IA to IIIA, EGFR-Mutant NSCLC (NORA)Jii Bum Lee, Su-Jin Choi, Hyo Sup Shim, et al.
JCI Insight|June 20, 2020
Combination of PD-L1 and PVR determines sensitivity to PD-1 blockadeBo Ryeong Lee, Sehyun Chae, Jihyun Moon, et al.
Tuberculosis and Respiratory Diseases|November 23, 2013
Plasminogen Activator Inhibitor Type 1 (PAI-1) A15T Gene Polymorphism Is Associated with Prognosis in Patients with EGFR Mutation Positive Pulmonary AdenocarcinomaJu Eun Lim, Moo Suk Park, Eun Young Kim, et al.
Journal for Immunotherapy of Cancer|December 15, 2021
Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancerChang Gon Kim, Gamin Kim, Kyung Hwan Kim, et al.
The EMBO Journal|March 14, 2022
Airway secretory cell fate conversion via YAP-mTORC1-dependent essential amino acid metabolismHae Yon Jeon, Jinwook Choi, Lianne Kraaier, et al.
Pageof 14